2023-06-14 16:22:22 ET
- PURE Bioscience press release ( OTC:PURE ): Q3 GAAP EPS of -$0.01.
- Revenue of $0.41M (-18.0% Y/Y).
For further details see:
PURE Bioscience GAAP EPS of -$0.01, revenue of $0.41M2023-06-14 16:22:22 ET
For further details see:
PURE Bioscience GAAP EPS of -$0.01, revenue of $0.41MMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
July 14 th -17 th , 2023, Long Beach, California Booth #429 PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, is set to unveil its newest food safety solutions at the 2024 International Association f...
PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, and AgroVet Alliance, FZE (“AVA”), have entered into a multi-year international...
Update on Business and PURE’s SDC-Based Antimicrobial Food Safety Solutions PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial...